Preloader
State Life Ins.
  • E-pay
  • اردو

Sinf e Aahan

Women play a significant role in our society. As homemakers or as professionals, women always prove to be one of the most significant pillars. But somehow in between a major aspect is neglected which is health. In recent years there have been more disability-adjusted life years (DALYs) by women to cancer globally than any other disease. According to WHO 2.3 million women were diagnosed with cancer globally in 2020.

This product intends to provide financial protection to women against the diagnosis of cancer at a very affordable cost.

Click the button to get Protected

    Benefit Structure:

    100% of Sum Assured is payable on diagnosis of the cancer verified by provision of the histopathological report.

    Coverage Period:

    Policy will be issued for a period of one year which may be renewed at the end of the policy year. Premium rates subject to review by State Life each year.

    Who Can Be Covered?

    All Pakistani females aged 18-64 will be eligible for this product.

    Initial Waiting Period:

    In the first policy year, coverage would commence after 90 days from the day a complete application is received by State Life along with the Full Premium. In case the policy is renewed in continuation of the coverage with State Life, the waiting period will be waived from the next year.



    Definitions:

    Cancer

    The diagnosis of a malignant tumor characterized by the uncontrolled growth and spread of malignant cells with invasion of normal tissue. The diagnosis of cancer must be verified by provision of the histopathological report. Cancer includes: leukaemia, malignant lymphoma including cutaneous lymphoma, Hodgkin's disease, malignant bone marrow disorders, and sarcoma. The following are excluded:

    • "Carcinoma in situ" or "cancer in situ", dysplasia, and all pre-malignant conditions.
    • Prostate cancer unless having progressed to at
       least TNM classification T2bN0M0
    • Any primary skin cancer other than malignant melanoma that has invaded beyond the epidermis (outer layer of skin)
    • Papillary cancer of the thyroid gland that is organ confined
    • All tumors and cancers in the presence of HIV infection.

    Condition

    • The first occurrence of cancer diagnosed by observing uncontrolled growth of and invasion of normal tissues by malignant cells in a histological specimen taken from the primary or secondary tumor. This is the definitive criteria, although not all cancers are covered; see 'Exclusions'.
    • Some definitions expand the requirement for histology to include 'confirmation by histological evidence of malignancy by a qualified oncologist or pathologist'; this is acceptable but not necessary as histology reports are prepared by specialists. Rarely a diagnosis of cancer is made on clinical grounds or histology is equivocal. In most of these circumstances, the absence of histological proof disqualifies a claim; admission of the claim requires careful consideration by a CMO with discussion with an oncologist if required.
    • In a primary tumor in the absence of vascular invasion, (stromal) invasion applies to carcinomas but not to sarcomas or cancers of the blood or lymphatic systems. This is why these tumors are explicitly mentioned.

    Exclusions

    "Carcinoma in situ" or "cancer in situ" or dysplasia or pre-malignant conditions or non-invasive cancers.

    These conditions are risk markers for invasive cancer but are not life-threatening or causes of significant morbidity except diffuse ('flat') non-papillary urinary bladder carcinoma in situ (Tis). Binet stage A Chronic Lymphatic Leukemia.

    In order to cope up with this prevalent disease and provide state of the art health care facalities to our women, State Life Insurance Corporation of Pakistan has come up with a cancer protection plan for women called as SINF-E-AAHAN Cancer Protection Plan (SACP).

    Any Pakistani national female aged from 18 to 64 years can avail SACP at very affordable annual premium. SACP pays 100% of the sum assured on diagnosis of cancer during the policy year.

    For details and benefit plan please refer to the attached brochure

    Click here for Product Detail